Cargando…
Functional Consequences of Mutations in Myeloproliferative Neoplasms
Driver mutations occur in Janus kinase 2 (JAK2), thrombopoietin receptor (MPL), and calreticulin (CALR) in BCR-ABL1 negative myeloproliferative neoplasms (MPNs). From mutations leading to one amino acid substitution in JAK2 or MPL, to frameshift mutations in CALR resulting in a protein with a differ...
Autores principales: | Constantinescu, Stefan N., Vainchenker, William, Levy, Gabriel, Papadopoulos, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171364/ https://www.ncbi.nlm.nih.gov/pubmed/34095761 http://dx.doi.org/10.1097/HS9.0000000000000578 |
Ejemplares similares
-
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders
por: Vainchenker, William, et al.
Publicado: (2018) -
CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients
por: Cassinat, Bruno, et al.
Publicado: (2020) -
Inferring the initiation and development of myeloproliferative neoplasms
por: Hermange, Gurvan, et al.
Publicado: (2022) -
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
por: Kjær, Lasse
Publicado: (2020) -
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
por: Aujla, Amandeep, et al.
Publicado: (2018)